Equity Profile
Post-Earnings Recap
BioMarin Pharmaceutical Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.87 | $1.80 | +0.11% |
| Revenue | N/A | $1.6B | N/A |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Texas Roadhouse, Inc. is a popular restaurant chain known for its casual dining experience and hand-cut steaks....
EPS
Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and revenues.
Revenue
Total revenue reflects the overall sales performance and customer traffic, which are vital for assessing growth.
Wall Street expectations, options signals, track record, and call prep available with Pro.
Mixed
Recent Transactions
Traded Mar 3, 2026 · disclosed Apr 7, 2026
$1,001.00–$15,000.00
Traded Jan 5, 2026 · disclosed Feb 13, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.